{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:15:57Z","timestamp":1793657757174,"version":"4.5.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.juro.2009.07.016","type":"journal-article","created":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T05:05:20Z","timestamp":1253163920000},"page":"2195-2203","source":"Crossref","is-referenced-by-count":559,"title":["Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model"],"prefix":"10.1097","volume":"182","author":[{"given":"Jesus","family":"Fernandez-Gomez","sequence":"first","affiliation":[{"name":"Department of Urology, Hospital Central of Asturias, University of Oviedo, Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Madero","sequence":"additional","affiliation":[{"name":"Department of Statistics, Hospital La Paz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Solsona","sequence":"additional","affiliation":[{"name":"Department of Urology, Instituto Valenciano de Oncolog\u00eda, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Unda","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital of Basurto, Bilbao, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Martinez-Pi\u00f1eiro","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital La Paz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelino","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital Juan Canalejo, A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Portillo","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital Marques Valdecilla, Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ojea","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital Xeral, Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Pertusa","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital Cruces, Bilbao, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Rodriguez-Molina","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital Clinico San Carlos, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Emilio","family":"Camacho","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital General, Jerez de la Frontera, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Rabadan","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital La Princesa, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ander","family":"Astobieta","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital Galdakao, Galdakao, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Montesinos","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital Virgen del Camino, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Isorna","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital Dr. Negrin, Las Palmas de Gran Canaria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Munta\u00f1ola","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital Alvarez-Buylla, Mieres, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabel","family":"Gimeno","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital La Mancha, Alcazar de San Juan, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Blas","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital Miguel Servet, Zaragoza, Spain for Club Urologico Espa\u00f1ol de Tratamiento Oncologico (CUETO)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Antonio","family":"Martinez-Pi\u00f1eiro","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital La Paz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl.","key":"10.1016\/j.juro.2009.07.016_bib1","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.eursup.2007.04.008","article-title":"Treatment of intermediate-risk non-muscle-invasive bladder cancer (NMIBC)","volume":"6","author":"Hendricksen","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2009.07.016_bib2","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.07.016_bib3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2009.07.016_bib4","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.eururo.2007.10.006","article-title":"Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Gu\u00e9rin: multivariate analysis of data from four randomized CUETO trials","volume":"53","author":"Fernandez-Gomez","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2009.07.016_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Statist Med"},{"key":"10.1016\/j.juro.2009.07.016_bib6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-5347(05)65469-9","article-title":"Prognostic value of a T helper 1 urinary cytokine response after intravesical bacillus Calmette-Guerin treatment for superficial bladder cancer","volume":"167","author":"Saint","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.07.016_bib7","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0022-5347(05)00973-0","article-title":"The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy","volume":"175","author":"Joudi","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.07.016_bib8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1046\/j.1464-410X.2002.02722.x","article-title":"Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical Bacille Calmette-Gu\u00e9rin with a reduced dose of 27 mg in superficial bladder cancer","volume":"89","author":"Mart\u00ednez-Pi\u00f1eiro","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2009.07.016_bib9","first-page":"947","article-title":"BCG immunotherapy for transitional-cell carcinoma in situ of the bladder","volume":"9","author":"Lamm","year":"1995","journal-title":"Oncology (Huntingt)"},{"key":"10.1016\/j.juro.2009.07.016_bib10","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0022-5347(05)67523-4","article-title":"Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin","volume":"163","author":"Brake","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.07.016_bib11","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0022-5347(01)69072-4","article-title":"Superficial bladder carcinoma treated with bacillus Calmette-Guerin: progression-free and disease specific survival with 10-year minimum followup","volume":"167","author":"Davis","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.07.016_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0090-4295(01)01603-X","article-title":"Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Gu\u00e9rin: 18-year experience","volume":"59","author":"Pansadoro","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.juro.2009.07.016_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.eururo.2005.03.021","article-title":"Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor","volume":"48","author":"Huguet","year":"2005","journal-title":"Eur Urol"},{"issue":"suppl.","key":"10.1016\/j.juro.2009.07.016_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.urology.2005.08.065","article-title":"Prognostic markers for bladder cancer: International consensus panel on bladder tumor markers","volume":"66","author":"Habuchi","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.juro.2009.07.016_bib15","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.juro.2007.05.126","article-title":"Survival following the diagnosis of noninvasive bladder cancer: WHO\/International Society of Urological Pathology versus WHO classification systems","volume":"178","author":"Schned","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.07.016_bib16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01.mou.0000240311.08701.55","article-title":"Lymphovascular invasion as a prognostic tool for advanced bladder cancer","volume":"16","author":"Algaba","year":"2006","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.juro.2009.07.016_bib17","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0022-5347(05)67706-3","article-title":"Outcomes after intravesical bacillus Calmette-Guerin are not affected by substaging of high grade T1 transitional cell carcinoma","volume":"163","author":"Kondylis","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.07.016_bib18","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized southwest oncology group study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.07.016_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-5347(05)64043-8","article-title":"Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal metaanalysis of comparative studies on recurrence and toxicity","volume":"169","author":"Bohle","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.07.016_bib20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1464-410X.2003.04655.x","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin is superior to mitomycin C in reducing tumor recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials","volume":"93","author":"Shelley","year":"2004","journal-title":"BJU Int"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534709017406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534709017406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2009.07.016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T21:49:59Z","timestamp":1651182599000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2009.07.016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1016\/j.juro.2009.07.016"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2009.07.016","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.3246962.2931060","asserted-by":"object"}]},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}